Cargando…
First person – Qingting Hu
First Person is a series of interviews with the first authors of a selection of papers published in Biology Open helping early-career researchers promote themselves alongside their papers. Qingting Hu is first author on ‘Role of ALDH1A1 and HTRA2 expression in CCL2/CCR2-mediated breast cancer cell g...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679412/ http://dx.doi.org/10.1242/bio.045484 |
_version_ | 1783441328860823552 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Biology Open helping early-career researchers promote themselves alongside their papers. Qingting Hu is first author on ‘Role of ALDH1A1 and HTRA2 expression in CCL2/CCR2-mediated breast cancer cell growth and invasion’, published in BIO. Qingting conducted the research described in this article while a Research Technician in Dr Nikki Cheng's lab at University of Kansas Medical Center, USA. She is now a Research Technician in the lab of Dr. Tonks Nicholas at Cold Spring Harbor Laboratory, USA, investigating downstream signaling mechanism of CCL2/CCR2 pathway in breast cancer progression. |
format | Online Article Text |
id | pubmed-6679412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-66794122019-08-12 First person – Qingting Hu Biol Open First Person First Person is a series of interviews with the first authors of a selection of papers published in Biology Open helping early-career researchers promote themselves alongside their papers. Qingting Hu is first author on ‘Role of ALDH1A1 and HTRA2 expression in CCL2/CCR2-mediated breast cancer cell growth and invasion’, published in BIO. Qingting conducted the research described in this article while a Research Technician in Dr Nikki Cheng's lab at University of Kansas Medical Center, USA. She is now a Research Technician in the lab of Dr. Tonks Nicholas at Cold Spring Harbor Laboratory, USA, investigating downstream signaling mechanism of CCL2/CCR2 pathway in breast cancer progression. The Company of Biologists Ltd 2019-07-15 /pmc/articles/PMC6679412/ http://dx.doi.org/10.1242/bio.045484 Text en © 2019. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/4.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Qingting Hu |
title | First person – Qingting Hu |
title_full | First person – Qingting Hu |
title_fullStr | First person – Qingting Hu |
title_full_unstemmed | First person – Qingting Hu |
title_short | First person – Qingting Hu |
title_sort | first person – qingting hu |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679412/ http://dx.doi.org/10.1242/bio.045484 |